These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4808172)

  • 21. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
    Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
    Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experiences with methadone maintenance in young adults (rehabilitation of heroin addicts with methadone: the public health approach versus the individual perspective).
    Johnson B; Corman AG; Khantzian EJ; Long J
    Proc Natl Conf Methadone Treat; 1973; 1():601-9. PubMed ID: 4808208
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of the semantic differential in determining male and female concept differences among methadone maintenance clients.
    McShane W; Christensen J
    Proc Natl Conf Methadone Treat; 1973; 1():562-73. PubMed ID: 4808202
    [No Abstract]   [Full Text] [Related]  

  • 25. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of methadone maintenance in the treatment of heroin and other opioid dependence--a current perspective].
    Kaminer Y
    Harefuah; 1993 Dec; 125(11):429-33. PubMed ID: 8112673
    [No Abstract]   [Full Text] [Related]  

  • 27. Profile of active and terminated patients in a methadone maintenance program.
    Quatrone D
    Proc Natl Conf Methadone Treat; 1973; 1():760-6. PubMed ID: 4808230
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone metabolism in individuals dependent on heroin and after methadone administration].
    Wilczek H; Stĕpán J
    Cas Lek Cesk; 2003; 142(10):606-8. PubMed ID: 14635425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone maintenance: results of treatment in heroin addict at Thanyarak Hospital (1990-1996).
    Verachai V; Dechongkit S; Patarakorn A; Lukanapichonchut L
    J Med Assoc Thai; 1998 Dec; 81(12):947-52. PubMed ID: 9916382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Employment discrimination of the methadone patient.
    Randell J
    Proc Natl Conf Methadone Treat; 1973; 1():52-5. PubMed ID: 4808195
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Methadone treatment of heroin addiction in family practice. Risks and guidelines].
    Hartmann H; Uchtenhagen A; Fuchs W; Pasi A
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):299-304. PubMed ID: 6709990
    [No Abstract]   [Full Text] [Related]  

  • 35. Treating heroin addiction: comparison of methadone therapy, hospital therapy without methadone, and therapeutic community.
    Vidjak N
    Croat Med J; 2003 Feb; 44(1):59-64. PubMed ID: 12590430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking during pregnancy and intention to quit: a profile of methadone-maintained women.
    Haug NA; Stitzer ML; Svikis DS
    Nicotine Tob Res; 2001 Nov; 3(4):333-9. PubMed ID: 11694200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for alcohol use patterns among methadone maintenance patients.
    Teplin D; Raz B; Daiter J; Varenbut M; Plater-Zyberk C
    Am J Drug Alcohol Abuse; 2007; 33(1):179-83. PubMed ID: 17366259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic determinants of planned methadone treatment.
    Rivers PA; Dobalian A; Oyana TJ; Bae S
    Am J Health Behav; 2006; 30(5):451-9. PubMed ID: 16893307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.